6-Hydroxyflavanone treats anxiety and chemotherapy-induced neuropathy in Sprague–Dawley rats

BackgroundCancer remains a predominant cause of death worldwide. The advent of effective chemotherapy has enormously decreased the mortality rate and increased the life expectancy of cancer patients. However, the adverse effects allied with chemotherapy contribute to the development of neurotoxicity...

Full description

Saved in:
Bibliographic Details
Main Authors: Shehla Akbar, Fazal Subhan, Rida Qamar, Aroosha Akbar, Naila Shahbaz, Muhammad Aamir, Nayyer Siddique, Salman Ul Islam
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-12-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2024.1486918/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846117409946075136
author Shehla Akbar
Fazal Subhan
Rida Qamar
Aroosha Akbar
Naila Shahbaz
Muhammad Aamir
Nayyer Siddique
Salman Ul Islam
author_facet Shehla Akbar
Fazal Subhan
Rida Qamar
Aroosha Akbar
Naila Shahbaz
Muhammad Aamir
Nayyer Siddique
Salman Ul Islam
author_sort Shehla Akbar
collection DOAJ
description BackgroundCancer remains a predominant cause of death worldwide. The advent of effective chemotherapy has enormously decreased the mortality rate and increased the life expectancy of cancer patients. However, the adverse effects allied with chemotherapy contribute to the development of neurotoxicity, anxiety, and depression.ObjectiveThe dual effects of a novel flavanone, 6-hydroxyflavanone (6-HF), were investigated in treating chemotherapy-induced neuropathy along with anxiolytic propensity.MethodsThe anti-neuropathy propensity of 6-HF was evaluated utilizing the cisplatin-induced neuropathy (CIN) model, whereas its anxiolytic activity was evaluated utilizing anxiety models, such as the elevated plus maze test (EPM), the staircase test, and the open-field paradigm.ResultCisplatin administration induced static and dynamic allodynia in the rats. Concomitant administration of 6-HF and cisplatin for four successive weeks remarkably reduced the chemotherapy-induced mechanical allodynia, evident from an elevation in the paw withdrawal threshold (PWT) and paw withdrawal latency (PWL). The anxiolytic-like activity of 6-HF in the EPM apparatus was confirmed by the increased number of entries in the open arm and time spent at the central platform, which was further confirmed by the enhanced head-dipping frequency in the same assay. A decrease in rearing behavior of the mice without suppression of the steps ascended further assured the anxiolytic-like potential of 6-HF. Additionally, the animals under investigation spent more time at the intersection of the open-field apparatus, further confirming the anxiolytic potential of 6-HF.Conclusion6-HF might be considered a potential therapeutic agent for counteracting two common adverse effects of chemotherapy, neurotoxicity and anxiety.
format Article
id doaj-art-5c4ad6bea83f40a48cf7932c7fb3ad12
institution Kabale University
issn 1663-9812
language English
publishDate 2024-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj-art-5c4ad6bea83f40a48cf7932c7fb3ad122024-12-18T10:47:38ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122024-12-011510.3389/fphar.2024.148691814869186-Hydroxyflavanone treats anxiety and chemotherapy-induced neuropathy in Sprague–Dawley ratsShehla Akbar0Fazal Subhan1Rida Qamar2Aroosha Akbar3Naila Shahbaz4Muhammad Aamir5Nayyer Siddique6Salman Ul Islam7Department of Pharmacy, CECOS University of IT and Emerging Sciences, Peshawar, PakistanDepartment of Pharmacy, CECOS University of IT and Emerging Sciences, Peshawar, PakistanArmed Forces Institute of Dentistry, Army Medical College, Rawalpindi, PakistanDepartment of Physical Therapy, Northwest College of Rehabilitation Sciences, Northwest Institute of Health Sciences, Peshawar, PakistanDepartment of Pharmacy, Sarhad Institute of Science and Information Technology, Peshawar, PakistanDepartment of Pharmacy, The University of Lahore, Lahore, PakistanDepartment of Molecular Biology and Genetics, Khyber Medical University, Peshawar, PakistanDepartment of Pharmacy, International Institute of Science, Arts, and Technology (IISAT), Gujranwala, PakistanBackgroundCancer remains a predominant cause of death worldwide. The advent of effective chemotherapy has enormously decreased the mortality rate and increased the life expectancy of cancer patients. However, the adverse effects allied with chemotherapy contribute to the development of neurotoxicity, anxiety, and depression.ObjectiveThe dual effects of a novel flavanone, 6-hydroxyflavanone (6-HF), were investigated in treating chemotherapy-induced neuropathy along with anxiolytic propensity.MethodsThe anti-neuropathy propensity of 6-HF was evaluated utilizing the cisplatin-induced neuropathy (CIN) model, whereas its anxiolytic activity was evaluated utilizing anxiety models, such as the elevated plus maze test (EPM), the staircase test, and the open-field paradigm.ResultCisplatin administration induced static and dynamic allodynia in the rats. Concomitant administration of 6-HF and cisplatin for four successive weeks remarkably reduced the chemotherapy-induced mechanical allodynia, evident from an elevation in the paw withdrawal threshold (PWT) and paw withdrawal latency (PWL). The anxiolytic-like activity of 6-HF in the EPM apparatus was confirmed by the increased number of entries in the open arm and time spent at the central platform, which was further confirmed by the enhanced head-dipping frequency in the same assay. A decrease in rearing behavior of the mice without suppression of the steps ascended further assured the anxiolytic-like potential of 6-HF. Additionally, the animals under investigation spent more time at the intersection of the open-field apparatus, further confirming the anxiolytic potential of 6-HF.Conclusion6-HF might be considered a potential therapeutic agent for counteracting two common adverse effects of chemotherapy, neurotoxicity and anxiety.https://www.frontiersin.org/articles/10.3389/fphar.2024.1486918/fullchemotherapy6-hydroxyflavanoneneurotoxicityanxietycancer
spellingShingle Shehla Akbar
Fazal Subhan
Rida Qamar
Aroosha Akbar
Naila Shahbaz
Muhammad Aamir
Nayyer Siddique
Salman Ul Islam
6-Hydroxyflavanone treats anxiety and chemotherapy-induced neuropathy in Sprague–Dawley rats
Frontiers in Pharmacology
chemotherapy
6-hydroxyflavanone
neurotoxicity
anxiety
cancer
title 6-Hydroxyflavanone treats anxiety and chemotherapy-induced neuropathy in Sprague–Dawley rats
title_full 6-Hydroxyflavanone treats anxiety and chemotherapy-induced neuropathy in Sprague–Dawley rats
title_fullStr 6-Hydroxyflavanone treats anxiety and chemotherapy-induced neuropathy in Sprague–Dawley rats
title_full_unstemmed 6-Hydroxyflavanone treats anxiety and chemotherapy-induced neuropathy in Sprague–Dawley rats
title_short 6-Hydroxyflavanone treats anxiety and chemotherapy-induced neuropathy in Sprague–Dawley rats
title_sort 6 hydroxyflavanone treats anxiety and chemotherapy induced neuropathy in sprague dawley rats
topic chemotherapy
6-hydroxyflavanone
neurotoxicity
anxiety
cancer
url https://www.frontiersin.org/articles/10.3389/fphar.2024.1486918/full
work_keys_str_mv AT shehlaakbar 6hydroxyflavanonetreatsanxietyandchemotherapyinducedneuropathyinspraguedawleyrats
AT fazalsubhan 6hydroxyflavanonetreatsanxietyandchemotherapyinducedneuropathyinspraguedawleyrats
AT ridaqamar 6hydroxyflavanonetreatsanxietyandchemotherapyinducedneuropathyinspraguedawleyrats
AT arooshaakbar 6hydroxyflavanonetreatsanxietyandchemotherapyinducedneuropathyinspraguedawleyrats
AT nailashahbaz 6hydroxyflavanonetreatsanxietyandchemotherapyinducedneuropathyinspraguedawleyrats
AT muhammadaamir 6hydroxyflavanonetreatsanxietyandchemotherapyinducedneuropathyinspraguedawleyrats
AT nayyersiddique 6hydroxyflavanonetreatsanxietyandchemotherapyinducedneuropathyinspraguedawleyrats
AT salmanulislam 6hydroxyflavanonetreatsanxietyandchemotherapyinducedneuropathyinspraguedawleyrats